ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
quacker
|
43K |
20M |
11 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
43K
|
20M
|
11
|
|
ASX - By Stock
|
RCE Medicine |
Re:
Recce Pharmaceuticals (ASX:RCE)
|
|
quacker
|
43 |
27K |
2 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
43
|
27K
|
2
|
|
ASX - By Stock
|
STX |
Re:
Ann: Completion of Capital Procurement & Close of SPP
|
|
quacker
|
63 |
30K |
1 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
63
|
30K
|
1
|
|
ASX - By Stock
|
WGO |
Re:
WGO - STX SP COJOINED
|
|
quacker
|
21 |
10K |
3 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
21
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
PCR London Valves
|
|
quacker
|
122 |
58K |
11 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
122
|
58K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
PCR London Valves
|
|
quacker
|
122 |
58K |
3 |
18/11/19 |
18/11/19 |
ASX - By Stock
|
122
|
58K
|
3
|
|
ASX - By Stock
|
STX |
Re:
Now at 20c !!!
|
|
quacker
|
87 |
45K |
0 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
87
|
45K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
TAVR/TMVR market projected to reach $8B by 2023
|
|
quacker
|
34 |
21K |
2 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
34
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
TAVR/TMVR market projected to reach $8B by 2023
|
|
quacker
|
34 |
21K |
10 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
34
|
21K
|
10
|
|
ASX - By Stock
|
WGO |
Re:
Ann: STX: West Erregulla Resource Statement
|
|
quacker
|
21 |
13K |
0 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
21
|
13K
|
0
|
|
ASX - By Stock
|
EXR |
Re:
Ann: Drilling Update
|
|
quacker
|
56 |
32K |
20 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
56
|
32K
|
20
|
|
ASX - By Stock
|
WGO |
Re:
Ann: STX: West Erregulla Resource Statement
|
|
quacker
|
21 |
13K |
10 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
21
|
13K
|
10
|
|
ASX - By Stock
|
STX |
Re:
Ann: West Erregulla Resource Statement
|
|
quacker
|
185 |
116K |
27 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
185
|
116K
|
27
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
quacker
|
152 |
87K |
3 |
09/11/19 |
09/11/19 |
ASX - By Stock
|
152
|
87K
|
3
|
|
ASX - By Stock
|
STX |
Re:
Petra Capital were buyers post flow rate announcment!
|
|
quacker
|
42 |
26K |
2 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
42
|
26K
|
2
|
|
ASX - By Stock
|
STX |
Re:
Petra Capital were buyers post flow rate announcment!
|
|
quacker
|
42 |
26K |
0 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
42
|
26K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Petra Capital were buyers post flow rate announcment!
|
|
quacker
|
42 |
26K |
2 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
42
|
26K
|
2
|
|
ASX - By Stock
|
STX |
Re:
Petra Capital were buyers post flow rate announcment!
|
|
quacker
|
42 |
26K |
1 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
42
|
26K
|
1
|
|
ASX - By Stock
|
EXR |
Re:
Ann: Drilling update
|
|
quacker
|
36 |
19K |
4 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
36
|
19K
|
4
|
|
ASX - By Stock
|
STX |
Re:
Ann: Trading Halt
|
|
quacker
|
293 |
172K |
7 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
293
|
172K
|
7
|
|
ASX - By Stock
|
STX |
Re:
Ann: Trading Halt
|
|
quacker
|
293 |
172K |
6 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
293
|
172K
|
6
|
|
ASX - By Stock
|
STX |
Re:
Ann: Trading Halt
|
|
quacker
|
293 |
172K |
0 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
293
|
172K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Ann: Pause in Trading
|
|
quacker
|
28 |
13K |
4 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
28
|
13K
|
4
|
|
ASX - By Stock
|
STX |
Re:
Ann: Outstanding West Erregulla Flow Test Results
|
|
quacker
|
359 |
230K |
4 |
28/10/19 |
28/10/19 |
ASX - By Stock
|
359
|
230K
|
4
|
|
ASX - By Stock
|
STX |
Re:
Ann: Outstanding West Erregulla Flow Test Results
|
|
quacker
|
359 |
230K |
4 |
28/10/19 |
28/10/19 |
ASX - By Stock
|
359
|
230K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Why Admedus’ shift to aortic valve replacement is good news for patients under 65
|
|
quacker
|
42 |
21K |
2 |
26/10/19 |
26/10/19 |
ASX - By Stock
|
42
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
0 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
289
|
133K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
4 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
289
|
133K
|
4
|
|
ASX - By Stock
|
EXR |
Re:
Ann: Operations Update
|
|
quacker
|
139 |
64K |
3 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
139
|
64K
|
3
|
|
ASX - By Stock
|
STX |
Re:
wanted AWE chart
|
|
quacker
|
6 |
5.8K |
6 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
6
|
5.8K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
3 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
289
|
133K
|
3
|
|
ASX - By Stock
|
EXR |
Re:
Operational update due
|
|
quacker
|
22 |
14K |
6 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
22
|
14K
|
6
|
|
ASX - By Stock
|
STX Oil & Gas |
Re:
Flow test due date?
|
|
quacker
|
144 |
93K |
3 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
144
|
93K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
2 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
289
|
133K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
8 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
289
|
133K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
quacker
|
289 |
133K |
4 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
289
|
133K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Musings of a ‘mug’ RI playing the Stockmarket.
|
|
quacker
|
63 |
29K |
0 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
63
|
29K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Musings of a ‘mug’ RI playing the Stockmarket.
|
|
quacker
|
63 |
29K |
4 |
13/10/19 |
13/10/19 |
ASX - By Stock
|
63
|
29K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
quacker
|
58 |
27K |
5 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
quacker
|
58 |
27K |
13 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Market entry / milestone dates
|
|
quacker
|
58 |
27K |
11 |
25/09/19 |
25/09/19 |
ASX - By Stock
|
58
|
27K
|
11
|
|
ASX - By Stock
|
STX |
Re:
Ann: West Erregulla 2 Update
|
|
quacker
|
168 |
109K |
22 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
168
|
109K
|
22
|
|
ASX - By Stock
|
WGO |
Re:
Ann: Trading Halt
|
|
quacker
|
201 |
94K |
7 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
201
|
94K
|
7
|
|
ASX - By Stock
|
WGO |
Re:
Ann: Trading Halt
|
|
quacker
|
201 |
94K |
1 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
201
|
94K
|
1
|
|
ASX - By Stock
|
EXR |
Re:
Ann: Investor Presentation
|
|
quacker
|
32 |
11K |
1 |
04/09/19 |
04/09/19 |
ASX - By Stock
|
32
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
quacker
|
7 |
5.7K |
1 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
7
|
5.7K
|
1
|
|
ASX - By Stock
|
STX |
Re:
Ann: Staggering Kingia Gas Discovery
|
|
quacker
|
625 |
416K |
9 |
01/09/19 |
01/09/19 |
ASX - By Stock
|
625
|
416K
|
9
|
|
ASX - By Stock
|
WGO |
Re:
Ann: STX: Staggering Kingia Gas Discovery **LEAVE**
|
|
quacker
|
134 |
57K |
18 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
134
|
57K
|
18
|
|
ASX - By Stock
|
ALC |
Re:
Alcidion launches new brand and website
|
|
quacker
|
2 |
1.6K |
3 |
07/08/19 |
07/08/19 |
ASX - By Stock
|
2
|
1.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
quacker
|
40 |
19K |
14 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
19K
|
14
|
|